About PPA   |   Contact Us   |   Sign In   |   Join Now
CE Webinar: New Advances in Psoriasis Treatment
Register Tell a Friend About This EventTell a Friend
 

Join us for this convenient online CE webinar!

 Export to Your Calendar 2/6/2018
When: Tuesday, February 6, 2018
10:00 to 11:30 AM
Where: Webinar
Access instructions provided upon registration
United States
Presenter: Jamie L. McConaha, PharmD, BCACP, NCTTP, CDE
Contact: Sara Bowden
(717) 234-6151 x. 2


Online registration is available until: 2/6/2018
« Go to Upcoming Event List  

New Advances in Psoriasis Treatment

 

Psoriasis is a chronic, inflammatory condition associated with substantial comorbidities, as well as physical and psychological complications. As the prevalence of psoriasis increases worldwide, there has been a plethora of new and unique treatments for this dermatologic condition. This CE program will enable pharmacists to become knowledgeable about current and emerging treatment options for patients with plaque psoriasis.


Presenter:


Jamie L. McConaha, PharmD, BCACP, NCTTP, CDE, Associate Professor of Pharmacy Practice, Duquesne University

Dr. Jamie McConaha is an Associate Professor of Pharmacy Practice at Duquesne University School of Pharmacy in the division of Clinical, Social and Administrative Sciences. After graduating from Duquesne, she completed a two-year academic and teaching fellowship with the school. During her fellowship, Dr. McConaha became interested in the topics of dermatology and cosmeceuticals, which led to the implementation of a new elective course at the university. Upon completion of her fellowship, Dr. McConaha joined the school of pharmacy’s clinical faculty. Dr. McConaha continues to teach her dermatology elective, as well as other dermatologic topics within the required curriculum.


Target Audience: All pharmacists

  
CE Credit: 1.5 Contact Hours (0.15 CEUs)

Program Objectives:

At the completion of this activity, the participant will be able to
1. Identify the clinical signs and symptoms of psoriasis, as well as common comorbidities associated with psoriatic disease
2. Apply standards for the classification of psoriasis to prompt a timely initiation of therapy
3. Implement treatment guidelines and evidence-based recommendations to provide long-term patient-centered management of moderate to severe psoriatic disease
  
Schedule:

9:55 AM to 10:00 AM - Attendees log in
10:00 AM to 11:30 AM - CE Program

  

Activity Type: Application-based

  

Cost:

PPA Members - Free
Non-Members - $45
   *Requests for cancellation refunds must be submitted to PPA at least one day in advance of the webinar. All refunds will be subject to a $5 administrative fee.

  

UAN: 0159-0000-18-003-L01-P

  

Requirements to receive credit: Participants must attend the entire program and complete an online evaluation survey within one week. PPA must have your CPE Monitor ID and birthday on file to issue credit.    


Click here to view current software requirements


The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Association Management Software Powered by YourMembership  ::  Legal